Protein Science· 2026Q1
Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions
- 8citations
- Q1SCImago
- 2026year
Short summary
A novel cryo-electron tomography workflow has been established and validated for imaging active SARS-CoV-2 virions within a Biosafety Level 3 (BSL-3) facility, revealing native pleomorphic features and surface spike redistribution.
AI-generated from the title and abstract; the full text is not read.
Key points
- A comprehensive cryo-EM workflow for BSL-3 environments was established and validated.
- Active SARS-CoV-2 virions were imaged using cryo-electron tomography under BSL-3 conditions.
- Unfixed viral particles showed pleomorphic features, confirming native structural characteristics.
- Spatial redistribution of surface spikes on SARS-CoV-2 virions was observed.
AI-generated from the title and abstract; the full text is not read.
Abstract
Understanding the structural properties of pathogenic viruses in their native, infectious state is critical for rational vaccine and drug development. However, conducting cryo-electron microscopy (cryo-EM) under biosafety level 3 (BSL-3) containment presents significant challenges. Here, we established and validated a high-end cryo-EM workflow within a BSL-3 facility, comprehensively integrating facility design, containment measures, sample handling, cryo-transfer systems, and decontamination protocols. To demonstrate the utility and reproducibility of this workflow, we applied cryo-electron tomography to investigate severe acute respiratory syndrome coronavirus 2 in its native, active state. Our observations confirm that unfixed viral particles display pleomorphic features comparable to those previously reported in fixed or inactivated preparations, validating that these structural characteristics represent native features rather than artifacts of chemical fixation. Furthermore, spatial redistribution of surface spikes was observed. The establishment of this robust BSL-3 cryo-EM workflow provides a practical blueprint for the structural characterization of emerging high-consequence pathogens, supporting pandemic preparedness, vaccine development, and antiviral discovery.
The authors' abstract, as published at the source. Protein Science, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Infectious Diseases
Infectious DiseasesMedicine